Also, CD28−Tim-3+CD4+ T cells from patients with hepatocellular carcinoma were reported to exhibit impaired ability to produce of IL-2 and IFNγ but their possible exhausted status was not ruled out (43). The gene discussed is IL2; the disease is hepatocellular carcinoma.